Fat Loss Research

Best Peptides for Weight Loss in India 2026

Published 2026-06-01 · Peptide Central Research Team

The landscape of fat loss peptide research has shifted dramatically over the past two years. GLP-1 receptor agonists, growth-hormone-releasing peptides, and mitochondrial activators now give researchers a multi-target toolkit. This guide covers every clinically studied fat loss peptide available in India — mechanisms, research dosing, and what the evidence currently supports.

Why Peptides for Fat Loss Research?

Small-molecule weight-loss drugs operate on one or two receptors. Peptides, by contrast, can simultaneously modulate appetite signalling, adipose lipolysis, insulin sensitivity, and energy expenditure. The result is a nuanced research space where compounds like Retatrutide are showing 24 % body-weight reduction in phase-3 trials — numbers that were unimaginable a decade ago.

GLP-1 / GIP / Glucagon Triple Agonists

Retatrutide

Retatrutide (LY3437943) is a single-molecule triple agonist targeting GLP-1, GIP, and glucagon receptors. The glucagon component significantly boosts hepatic fat oxidation and basal metabolic rate — something pure GLP-1 agonists cannot achieve. Phase-2 data showed 17.5 % mean weight loss at 24 weeks; phase-3 figures exceed 24 %. Research dosing starts at 2 mg/week subcutaneous, titrating to 8–12 mg/week over 12–16 weeks. It is among the most promising fat loss peptides India researchers can currently access.

Tirzepatide

Tirzepatide is a dual GLP-1/GIP agonist with an extensive evidence base. SURMOUNT-1 reported 22.5 % weight loss at 72 weeks on 15 mg/week. GIP co-agonism improves insulin sensitivity independently of weight, making Tirzepatide valuable in metabolic syndrome models. Research dosing follows the 2.5 → 5 → 10 → 15 mg/week titration schedule used in clinical trials.

Growth Hormone Fragment & Releasing Peptides

AOD-9604

AOD-9604 is the C-terminal fragment (residues 177–191) of human growth hormone. It retains the lipolytic activity of hGH — stimulating beta-3 adrenergic receptors on adipocytes — without the insulin-desensitising effects of full hGH. Research dosing is 250–300 mcg/day subcutaneous, ideally administered fasted in the morning. AOD-9604 is one of the best-studied peptides for localised adipose reduction and is a staple in fat loss peptide research in India.

Tesamorelin

Tesamorelin is a GHRH analogue that stimulates endogenous growth hormone secretion. Its FDA approval for HIV-associated lipodystrophy gives it a stronger clinical evidence base than most research peptides. Research shows significant reduction in visceral adipose tissue (VAT), with a mean 15 % VAT reduction at 26 weeks on 2 mg/day. It also improves IGF-1 levels and cognitive markers, making it a popular multi-target compound.

Mitochondrial & Metabolic Peptides

MOTS-C

MOTS-C is a mitochondrial-derived peptide (MDP) encoded in the 12S rRNA region of mitochondrial DNA. It activates AMPK via the AICAR pathway, improving glucose uptake into skeletal muscle and reducing adipogenesis. Animal studies show dramatic protection against diet-induced obesity even without caloric restriction. Research dosing is 5–10 mg/week subcutaneous, making it a cost-effective add-on to GLP-1-based protocols.

Comparing the Research Candidates

For visceral fat and metabolic syndrome models, Retatrutide and Tirzepatide show the largest effect sizes. For subcutaneous adipose research, AOD-9604 remains the most direct mechanistic tool. Tesamorelin is the first choice for GH-axis and VAT-specific work. MOTS-C is best studied alongside lifestyle variables given its AMPK-centric mechanism.

All of these peptides require reconstitution with bacteriostatic water prior to use. Use our free BAC Water Reconstitution Calculator to determine exact concentration, mcg per IU, and syringe draw for any vial size and dose combination.

Sourcing HPLC-Verified Fat Loss Peptides in India

Purity is the single biggest variable in peptide research. A nominally dosed vial of Retatrutide at 60 % purity produces meaningless data compared to a 99 % HPLC-verified batch. Peptide Central stocks the full range of fat loss peptides with independent HPLC certification and COA included with every order. Pan-India delivery with COD available.

Frequently Asked Questions

Which peptide shows the highest fat loss in research?

Retatrutide (triple GLP-1/GIP/glucagon agonist) currently shows the highest body-weight reduction in trials — over 24 % at 48 weeks — of any peptide in research.

What is AOD-9604 and how does it work?

AOD-9604 is a fragment of human growth hormone (residues 177–191) that stimulates beta-3 adrenergic receptors on fat cells, promoting lipolysis without the insulin resistance associated with full hGH.

Can Tesamorelin and AOD-9604 be used together?

Mechanistically they are complementary — Tesamorelin raises endogenous GH (targeting visceral fat) while AOD-9604 acts directly on adipocytes. Many researchers combine them; dosing is independent.

How do I calculate the draw volume for fat loss peptides?

Use our BAC Water Reconstitution Calculator — enter vial size, BAC water volume, and your target dose to get exact IU draw on an insulin syringe instantly.

Ready to Order?

All fat loss peptides available with 99% HPLC-verified purity, COA included, pan-India COD delivery.

Order on WhatsApp